Skip to main content
. 2019 Aug 28;8(8):2651–2655. doi: 10.4103/jfmpc.jfmpc_432_19

Table 2.

AMACR/HMWCK and P63 status

AMACR/HMWCK and P63 status No of cases (n=80) Percentage

Benign (40) Malignant (40)
AMACR+/HMWCK and P63+ 0 0 0
AMACR+/HMWCK and P63- 0 36 45
AMACR-/HMWCK and P63+ 40 0 50
AMACR-/HMWCK and P63- 0 4 5
Total 40 40 100